Juefeng Wan

2.0k total citations
64 papers, 743 citations indexed

About

Juefeng Wan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juefeng Wan has authored 64 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 29 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juefeng Wan's work include Colorectal Cancer Surgical Treatments (28 papers), Colorectal and Anal Carcinomas (20 papers) and Colorectal Cancer Treatments and Studies (12 papers). Juefeng Wan is often cited by papers focused on Colorectal Cancer Surgical Treatments (28 papers), Colorectal and Anal Carcinomas (20 papers) and Colorectal Cancer Treatments and Studies (12 papers). Juefeng Wan collaborates with scholars based in China, United States and Switzerland. Juefeng Wan's co-authors include Zhen Zhang, Guichao Li, Ji Zhu, Lijun Shen, Yaqi Wang, Fan Xia, Sanjun Cai, Hui Zhang, Lifeng Yang and Ye Xu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Brain Research.

In The Last Decade

Juefeng Wan

57 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juefeng Wan China	17	448	204	178	139	108	64	743
Jean‐Marie Nogaret Belgium	19	514 1.1×	222 1.1×	185 1.0×	392 2.8×	140 1.3×	49	990
Maria Gule-Monroe United States	12	374 0.8×	111 0.5×	183 1.0×	50 0.4×	137 1.3×	43	837
Wen‐Ling Kuo Taiwan	15	192 0.4×	193 0.9×	98 0.6×	196 1.4×	266 2.5×	60	805
Matthew J. Goldstein United States	14	318 0.7×	137 0.7×	83 0.5×	103 0.7×	212 2.0×	29	975
Rongkui Luo China	14	169 0.4×	133 0.7×	227 1.3×	77 0.6×	187 1.7×	83	713
Tu Dan United States	15	191 0.4×	106 0.5×	309 1.7×	190 1.4×	160 1.5×	52	749
Salvatore Di Lauro Italy	16	231 0.5×	166 0.8×	209 1.2×	116 0.8×	303 2.8×	54	1.1k
Naoki Urakawa Japan	13	343 0.8×	331 1.6×	216 1.2×	94 0.7×	204 1.9×	89	821
Haiqun Xing China	16	406 0.9×	252 1.2×	105 0.6×	203 1.5×	85 0.8×	41	774
Ilaria Maggio Italy	15	375 0.8×	110 0.5×	222 1.2×	81 0.6×	114 1.1×	30	716

Countries citing papers authored by Juefeng Wan

Since Specialization

Citations

This map shows the geographic impact of Juefeng Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juefeng Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juefeng Wan more than expected).

Fields of papers citing papers by Juefeng Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juefeng Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juefeng Wan. The network helps show where Juefeng Wan may publish in the future.

Co-authorship network of co-authors of Juefeng Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Juefeng Wan. A scholar is included among the top collaborators of Juefeng Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juefeng Wan. Juefeng Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ababneh, Hazim, Andrea K. Ng, Juefeng Wan, et al.. (2025). 5-5-5 ABRT (Dose of 5 Gy per Fraction for up to 5 Fractions Over 5 Weeks Adaptive Bridging Radiation Therapy)—Artificial Intelligence Enters the CAR (-T) (Chimeric Antigen Receptor-T) in Relapsed/Refractory Large B Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 122(4). 936–948. 3 indexed citations

Li, Yida, Fan Xia, Yun Deng, et al.. (2025). SIRPα + CD209 + cell: a specialized antigen-presenting cell that contributes to anti-SIRPα/RT therapy in colorectal cancer. Cancer Immunology Immunotherapy. 74(5). 167–167.

Wan, Juefeng, et al.. (2024). On the Initial Layer and the Limit Behavior for Chemotaxis System with the Effect of Fluid in Fourier Space. Acta Mathematicae Applicatae Sinica English Series. 40(4). 1015–1024.

Wan, Juefeng, Ruiyan Wu, Lijun Shen, et al.. (2023). TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial. Frontiers in Oncology. 13. 1304767–1304767. 2 indexed citations

Wang, Kun, et al.. (2023). The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection. Cancer Medicine. 12(8). 9482–9495. 7 indexed citations

Zhang, Lijie, Minghe Wang, Jing Zhang, et al.. (2023). Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis. Therapeutic Advances in Medical Oncology. 15. 2642691–2642691. 3 indexed citations

Zhou, Shujuan, Chenchen Wang, Lijun Shen, et al.. (2023). Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT). Frontiers in Oncology. 13. 1274487–1274487. 4 indexed citations

Shen, Lijun, Juefeng Wan, Hai Zhang, et al.. (2023). 601P Short-course radiotherapy based total neoadjuvant therapy combined with PD-1 inhibitor for locally advanced rectal cancer: Preliminary findings of TORCH. Annals of Oncology. 34. S433–S433.

Wang, Yaqi, Lijun Shen, Juefeng Wan, et al.. (2022). Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation. Frontiers in Immunology. 13. 1067036–1067036. 28 indexed citations

10.

Wang, Yaqi, Lijun Shen, Juefeng Wan, et al.. (2022). Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH). BMC Cancer. 22(1). 274–274. 30 indexed citations

11.

Zhang, Zhiyuan, Lijun Shen, Yan Wang, et al.. (2021). MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients. Frontiers in Oncology. 11. 17 indexed citations

12.

Wang, Jiazhou, Yujiao Li, Jiayuan Peng, et al.. (2021). An Artificial Intelligence-Based Full-Process Solution for Radiotherapy: A Proof of Concept Study on Rectal Cancer. Frontiers in Oncology. 10. 616721–616721. 23 indexed citations

13.

Li, Chao, Lifeng Yang, Juefeng Wan, et al.. (2020). The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial. Clinical Colorectal Cancer. 19(2). e58–e69. 16 indexed citations

14.

Liu, Kaitai, et al.. (2017). Prognostic Impact of Different Histological Types on Gastric Adenocarcinoma: a Surveillance, Epidemiology, and End Results Database Analysis. Pathology & Oncology Research. 23(4). 881–887. 22 indexed citations

15.

Wan, Juefeng, et al.. (2016). Sex, Race, and Age Disparities in the Improvement of Survival for Gastrointestinal Cancer over Time. Scientific Reports. 6(1). 29655–29655. 7 indexed citations

16.

Liu, Kaitai, et al.. (2016). The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis. Journal of Cancer Research and Clinical Oncology. 143(2). 313–320. 7 indexed citations

17.

Wan, Juefeng, et al.. (2015). Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?. Radiation Oncology. 10(1). 162–162. 33 indexed citations

18.

Wan, Juefeng, et al.. (2014). Incidence of Chemotherapy- and Chemoradiotherapy-Induced Amenorrhea in Premenopausal Women With Stage II/III Colorectal Cancer. Clinical Colorectal Cancer. 14(1). 31–34. 35 indexed citations

19.

Wan, Juefeng, et al.. (2012). Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patients. Journal of Radiation Research. 54(2). 285–291. 39 indexed citations

20.

Hai, Jian, Juefeng Wan, Qi Lin, et al.. (2009). Cognitive dysfunction induced by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations. Brain Research. 1301. 80–88. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact